Website Header with Language Selector and Dropdowns

Glibenclamide EP Impurity B


Catalog Number: CL-GBC-03
CAS No.: 21165-77-5
Mol.F: C18H19ClN2O6S
Mol.W: 426.9
Inv. Status: In Stock

Chemical Name: Methyl ((4-(2-(5-chloro-2-methoxybenzamido)ethyl)phenyl)sulfonyl)carbamate.

Country of Origin: India

Product Category: Glibenclamide Impurities


Glibenclamide EP Impurity B is identified by CAS No. 21165-77-5 and is chemically known as Methyl ((4-(2-(5-chloro-2-methoxybenzamido)ethyl)phenyl)sulfonyl)carbamate.

Glibenclamide EP Impurity B is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Glibenclamide.

Page Keywords: Buy Glibenclamide EP Impurity B | Purchase Glibenclamide EP Impurity B | Glibenclamide EP Impurity B suppliers | Glibenclamide EP Impurity B manufacturers | Glibenclamide EP Impurity B price | Glibenclamide EP Impurity B Importer | Glibenclamide EP Impurity B Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-GBC-01
CAS No: 10238-21-8
Mol Wt: 494
Mol F: C23H28ClN3O5S
Inv. Status: Custom Synthesis
CAT No: CL-GBC-07
CAS No: 5195-87-9
Mol Wt: 435.6
Mol F: C22H33N3O4S
Inv. Status: Custom Synthesis
CAT No: CL-GBC-02
CAS No: 16673-34-0
Mol Wt: 368.8
Mol F: C16H17ClN2O4S
Inv. Status: In Stock
CAT No: CL-GBC-04
CAS No: 10079-35-3
Mol Wt: 450.6
Mol F: C22H34N4O4S
Inv. Status: Custom Synthesis
CAT No: CL-GBC-05
CAS No: 38160-73-5
Mol Wt: 468
Mol F: C21H26ClN3O5S
Inv. Status: Custom Synthesis
CAT No: CL-GBC-06
CAS No: 57334-89-1
Mol Wt: 528.5
Mol F: C23H27Cl2N3O5S
Inv. Status: Custom Synthesis
CAT No: CL-GBC-09
CAS No: 80762-77-2
Mol Wt: 368.8
Mol F: C16H17ClN2O4S
Inv. Status: Custom Synthesis
CAT No: CL-GBC-10
CAS No: 158751-80-5
Mol Wt: 368.8
Mol F: C16H17ClN2O4S
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.